Ajinomoto Co. is a global manufacturer of high-quality seasonings, processed foods, beverages, amino acids, pharmaceuticals and specialty chemicals. For many decades Ajinomoto Co. has contributed to food culture and human health through wide-ranging application of amino acid technologies. Today, the company is becoming increasingly involved with solutions for improved food resources, human health and global sustainability. Founded in 1909 and now operating in 26 countries, Ajinomoto Co. had net sales of JPY 1,197.3 billion (USD 15.1 billion) in fiscal 2011. The Ajinomoto Group Standards of Business Conduct (hereinafter the "Standards of Conduct") describe the conduct that every member of the Ajinomoto Group must understand and practice every day in order to implement the Ajinomoto Group Philosophy in accordance with the Ajinomoto Group Way. The Standards of Conduct also represent the commitments made to all stakeholders by Ajinomoto Group companies. Ajinomoto aim to be "a group of companies that contributes to human health globally" by continually creating unique value to benefit customers. To become a global group of food companies centered on the world's No. 1 seasoning business. To become a global group of aminoscience companies that contributes to humankind with the world's No. 1 amino acid technology. To become a group of health-promoting companies with a scientific approach to good taste and health.

Guangdong Meige Gene Technology Co., Ltd., established on 2016-08-09, Business scope includes general business items:Technical Services for Biotechnology,technology transfer,technology development,technical consulting;Medical technology research and development;computer technology development,Technical Services;Domestic Trade(Except for licensed and approved products);Operating import and export business(law,Administrative regulations,Except for items prohibited by the State Council,Restricted projects must obtain a license before operating);Conference and exhibition,in the advertising business;Corporate Image Planning;cultural exchange;Cultural Event Planning;Etiquette service,account Serive;marketing planning;Exhibition planning;Kit development and sales.,The licensing program is:Technology research and development and production of biotechnology products;vocational skills training(Excludes vocational skills training programs that require license approval to operate);Kit production and sales;Fluorescence quantificationPCRInstrument production and sales;Production and sales of medical instruments;Licensed medical device business.

Kemira Oyj engages in the provision of water quality and quantity management solutions, which improves energy, water, and raw material efficiency. It operates through the Pulp and Paper, and Industry and Water segments. The Pulp and Paper segment develops and sells products to fulfill customer needs, ensuring the portfolio of products and services for paper wet-end, focusing on packaging and board, as well as tissue products. The Industry and Water segment supports municipalities and water intensive industries in the efficient and sustainable utilization of resources. The company was founded in 1920 and is headquartered in Helsinki, Finland.

Pfizer Inc. (NYSE: PFE, /ˈfaɪzər/) is an American multinational pharmaceutical corporation headquartered in New York City was founded in 1849, based in New York City and was listed on New York Stock Exchange. It is one of the world's largest pharmaceutical companies. It is listed on the New York Stock Exchange, and its shares have been a component of the Dow Jones Industrial Average since 2004. Pfizer ranked No. 57 on the 2018 Fortune 500 list of the largest United States corporations by total revenue.

N.V. Organon engages in the development, manufacture, and sale of prescription medicines. It offers products for cardiovascular diseases, fertility, gynecology, anesthesia, respiratory, consumer health care, neuroscience as well as immunology, animal health, and oncology. Its products include mometasone furoate inhalation powder, moxifloxacin, pegylated liposomal doxorubicin HCI, desogestrel, desloratadine, sun care, flu medicine, foot care, follitropin beta, formoterol fumarate inhalation powder, hormone therapy, and canine vaccines. The company was founded in 1923 and is headquartered in Oss, the Netherlands.

4D is a world leader in the development of live biotherapeutics, a novel and emerging class of drugs, defined by the FDA as biological products that contain a live organism, such as a bacteria, that is applicable to the prevention, treatment or cure of a disease. 4D has developed a proprietary platform, MicroRx, that rationally identifies novel bacteria that have a precise and evolved therapeutic effect. All of 4D's live biotherapeutic products are orally delivered single strains of bacteria that are naturally found in the healthy human gut. 4D currently has a pipeline of 15 therapeutic programmes covering autoimmune diseases, CNS disorders and cancer; with two programmes in patient trials, and the expectation to initiate another three programmes over the coming twelve months.

Engages in developing, producing and selling pharmaceutical and chemical products

Zhejiang Sci-Tech University Shaoxing Biomedical Research Institute Co., Ltd., established on 2019-10-28, Business scope includes R&D and pilot test of biopharmaceutical products,analysis test,technology transfer,Technical Services,Technical consulting and technical training(Items that do not require a school-running permit and a vocational skills permit);Biotechnology R&D and Application;Scientific and technological research and development and related consulting;Business Consulting;House to rent;Conference Services;Expo Services;Technology intermediary service;Patent Consulting;Business Management Consulting;Sales of experimental equipment;laboratory equipment(Does not contain medical devices)research and development,Sales;laboratory materials(Does not contain food,medicine,Hazardous Chemicals and Precursors)promotion of;Prepackaged food sales;Technology development of biological cell culture technology and medium,Bioreactor Design,Technical development of animal vaccines and diagnostic reagents,Achievement transfer;Import and export of goods and technology.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Botanix Pharmaceuticals is a pharmaceutical company that focuses on the treatment of skin diseases. Its mission is to improve the lives of patients battling acne, psoriasis, and atopic dermatitis by providing new treatment options for conditions that are currently inadequately addressed or are treated with therapeutics that are burdened with side effect profiles. The company is harnessing the untapped potential of a synthetic active pharmaceutical ingredient known as cannabidiol, which is currently being studied for the treatment of epilepsy, pain, arthritis, and schizophrenia, amongst other indications. Botanix is preparing for human trials utilizing synthetic cannabidiol in a proprietary drug delivery system (PermetrexTM) for direct skin delivery of the therapy.

Stone Seed provide seed products to help maximize yield potential. They have provided their farmers with the products, service and relationships. They offer products such as corn, soybeans, wheat and more. Likewise, they evaluate products based on the latest science and use extensive field-testing to help increase yield potential and minimize risk.

Shanghai Institutes for Biological Sciences CAS is a private company headquartered in Shanghai, China, that operates as researching agency.

Part of Koninklijke Coöperatie Cosun UA, Royal Nedalco BV is a company headquartered in Bergen op Zoom, the Netherlands, that produces natural ethanols.

Denka Corp., part of Denka Co., Ltd., is an American company located in New York, NY. The firm manufactures and distributes chemical products.

Seed Health is a biotechnology company that provides therapeutics, consumer health innovations, and environmental solutions. In collaboration with academic researchers, they advance breakthrough discoveries in the microbial sciences.

DSM IP Assets BV, a subsidiary of Koninklijke DSM NV, is a company headquartered in Heerlen, the Netherlands, that develops and produces nutrition, pharmacy & material science products.

Bayer AG engages in the development, manufacture and distribution of products in the areas of health care, nutrition and high-tech materials. It operates through the following segments: Pharmaceuticals, Consumer Health, Crop Science, Animal Health and Covestro. The Pharmaceuticals segment engages in the development, production and marketing of prescription products for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology and ophthalmology; diagnostic imaging equipment and the necessary contrast agents. The Consumer Health segment manufactures and markets products in the dermatology, dietary supplement, analgesic, gastrointestinal, cold, allergy, sinus and flu, foot care and sun protection categories. The CropScience segment includes seeds and plant traits, crop protection and nonagricultural pest control. The Animal Health segment offers prescription and nonprescription veterinary products. The Covestro segment provides raw materials for polyurethanes; polycarbonate granules and sheets; raw materials for coatings, adhesives and sealants; and by-products of polyether production and of chlorine production and use. The company was founded by Friedrich Bayer and Johann Friedrich Westkott on August 1, 1863 and is headquartered in Leverkusen, Germany.